Search - tctmd.com

Displaying 661 - 680 of 706

Sort: Relevancy | Date

Presentation TCT 2013

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Anita Asgar

October 28, 2013

News Daily News

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

October 25, 2013

News Daily News

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

October 23, 2013

News Daily News

‘Obesity Paradox’ Observed in TAVR Patients

Caitlin E. Cox

October 15, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Transfemoral Access Not Only Option for TAVR

Yael L. Maxwell

October 04, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Daily News

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

L.A. McKeown

July 24, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

News Daily News

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

Caitlin E. Cox

July 19, 2013

Presentation Transradial 2013

Transradial Skills in Structural Heart Disease?

Presenter: Josep Rod?s-Cabau

June 28, 2013

News Daily News

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Yael L. Maxwell

May 31, 2013

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

News Daily News

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

L.A. McKeown

May 13, 2013

News Daily News

Small Study Supports Transaortic TAVR as Better Option Than Transapical

Jason Kahn

April 12, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Daily News

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

Jason Kahn

February 11, 2013

Presentation TCT 2013

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Presenter: Chad Kliger, Bryce Einhorn, Vladimir Jelnin, Leandro Maranan, Gila Perk, itzhak kronzon, Howard Cohen, Carlos Ruiz

January 31, 2013

News Daily News

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

Caitlin E. Cox

November 12, 2012

Advertisement

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

PARTNER: Lung Disease No Barrier to TAVR But Increases Mortality Risk

Clinical Inoperability in TAVR Patients Carries Worse Prognosis than Technical Factors

‘Obesity Paradox’ Observed in TAVR Patients

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Transfemoral Access Not Only Option for TAVR

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Una Comparativa de Tratamientos contra EAC Multivaso halla una Preservación LVEF Similar a los 10 Años

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

Transradial Skills in Structural Heart Disease?

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Tumor Marker Predicts TAVR Outcomes

Post-TAVR Coronary Obstruction Risk Low, Linked to Unfavorable Anatomic Features

Small Study Supports Transaortic TAVR as Better Option Than Transapical

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

A-fib—Whether New or Preexisting—Raises Mortality in Patients Undergoing TAVR

Long-term Safety and Efficacy of Percutaneous Left Ventricular Transapical Access and Closure for Structural Heart Disease Interventions

Transfemoral—But Not Transapical—TAVR More Cost-Effective Than Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content